In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Vertebral artery ostium stenosis: Treatment with vertebral artery stenting – Long-term clinical and angiographic Results -

    Final Number:
    1111

    Authors:
    Young Woo Kim MD; Seong Rim Kim MD; Min Woo Baik MD; Hoon Kim

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2013 Annual Meeting

    Introduction: The optimal management of patients with symptomatic severe vertebral artery ostium (VAO) stenosis is still unclear. Although stent-assisted angioplasty is thought to be a safe treatment option, the main concerns related to treating VAO stenosis with stents have been the rate of restenosis and the uncertain long-term results. We analyzed the long-term outcome of patients with VAO stenosis who received vertebral artery stenting (VAS).

    Methods: One hundred nineteen patients with VAO stenosis were treated with stent placement over a period of 10 years. All patients were retrospectively analyzed. The indication criteria for this treatment were symptomatic severe VAO stenoses (> 60%) and asymptomatic severe VAO stenoses (> 60%) with incidentally detected infarction in the posterior circulation or with severe bilateral VAO stenosis, contralateral VA occlusion, or contralateral hypoplastic VA.

    Results: Technical success was 100%. Angiographic evaluation at a mean 12.2 months (range from 3 ~ 68 months) uncovered restenosis in 10 vessels (8.4%; 5 in bare-metal stent group and 5 in drug-eluting stent group) and occlusion in 3 (2.5%; 1 in bare-metal stent group and 2 in drug-eluting stent group). Two patients (1.7%) had recurrent stroke in stented-vessel territories at 3 months with angiographic evidence of in=stent occlusion and 48 months after the procedure, respectively.

    Conclusions: VAS can be safely and effectively performed with a low rate of recurrent stroke in the territory of the treated vessel.

    Patient Care: In this study, our patients had a very low rate of symptom recurrence after treatment. Therefore, VAS can be safely and effectively performed with a low rate of recurrent stroke in the territory of the treated vessel.

    Learning Objectives: By the conclusion of this session, participants should be able to 1)describe the importance of VAO stenosis as a potential source of posterior circulation ischemic stroke. 2)identify the fact that VAO stenting could be an effective treatment for VAO stenosis.

    References: 1. Hatano T, Tsukahara T, Miyakoshi A, Arai D, Yamaguchi S, Murakami M. Stent placement for atherosclerotic stenosis of the vertebral artery ostium: angiographic and clinical outcomes in 117 consecutive patients. Neurosurgery. 2011;68(1):108-16 2. Al-Ali F, Barrow T, Duan L, Jefferson A, Louis S, Luke K, Major K, Smoker S, Walker S, Yacobozzi M. Vertebral artery ostium atherosclerotic plaque as a potential source of posterior circulation ischemic stroke: result from borgess medical center vertebral artery ostium stenting registry. Stroke. 2011;42(9):2544-9.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy